FEATURED/ARCHIVES (04/05/24)
The Occurrence of Adverse Drug Reactions Reported for Attention Deficit Hyperactivity Disorder (ADHD) Medications in the Pediatric Population: A Qualitative Review of Empirical Studies · December 2011
Articles
Neuropsychiatric Disease and Treatment
Systematic Review of Suicidal Behaviors Related to Methylphenidate and Atomoxetine in Patients with Attention Deficit Hyperactivity Disorder · April 2023
Articles
Journal of the Korean Academy of Child and Adolescent Psychiatry
Amphetamines, Atomoxetine and the Risk of Serious Cardiovascular Events in Adults · January 2013
Articles
PLOS ONE
Methylphenidate and the Risk of Burn Injury among Children with Attention-Deficit/Hyperactivity Disorder · July 2020
Articles
Epidemiology and Psychiatric Sciences
The Effect of OROS Methylphenidate on the Sleep of Children with Attention-Deficit/Hyperactivity Disorder · March 2010
Abstracts
International Clinical Psychopharmacology
Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder · January 2019
Articles
NCBI>Journal of Child and Adolescent Psychopharmacology
Comparative Acute Efficacy and Tolerability of OROS and Immediate Release Formulations of Methylphenidate in the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder · September 2007
Articles
BMC Psychiatry
Efficacy and Tolerability of Psychostimulants for Symptoms of Attention-Deficit Hyperactivity Disorder in Preschool Children: A Systematic Review and Meta-Analysis · February 2023
Articles
European Psychiatry
Risk of Respiratory Infectious Diseases and the Role of Methylphenidate in Children with Attention-Deficit/Hyperactivity Disorder: A Population-Based Cohort Study · May 2021
Articles
International Journal of Environmental Research and Public Health
Diagnoses of Cardiovascular Disease or Substance Addiction/Abuse in US Adults Treated for ADHD with Stimulants or Atomoxetine: Is Use Consistent with Product Labeling? · January 2018
Articles
Drugs-Real World Outcomes
A Case of Recurrent Pneumothorax Related to Oral Methylphenidate · August 2015
Articles
Journal of Thoracic Disease
Efficacy and Safety of Guanfacine Extended-Release in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled Study · April 2020
Abstracts
Journal of Clinical Psychiatry
Stimulants for Kids with ADHD: How to Proceed Safely · February 2014
Articles
Journal of Family Practice
Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults with Attention-Deficit/Hyperactivity Disorder · September 2008
Abstracts
Journal of Clinical Psychiatry
Association Between Prenatal Exposure to Antipsychotics and Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Preterm Birth, and Small for Gestational Age · August 2021
Multimedia (Interviews-Authors)
JAMA Internal Medicine
Titrating Optimal Dose of Osmotic-Controlled Release Oral Delivery (OROS)-Methylphenidate and Its Efficacy and Safety in Korean Children with ADHD: A Multisite Open Labeled Study · September 2012
Articles
Psychiatry Investigation
Comparative Mortality Risk in Adult Patients with Schizophrenia, Depression, Bipolar Disorder, Anxiety Disorders, and Attention-Deficit/Hyperactivity Disorder Participating in Psychopharmacology Clinical Trials · August 2013
Articles
JAMA Psychiatry
ADHD Medication Use Following FDA Risk Warnings · September 2012
Articles (Manuscripts-Versions)
PubMed Central>Journal of Mental Health Policy and Economics
Stimulant Therapy and Risk for Subsequent Substance Use Disorders in Male Adults with ADHD: A Naturalistic Controlled 10-Year Follow-Up Study · May 2008
Articles
American Journal of Psychiatry